Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Soricimed Biopharma Inc.”

12 pharma patents match "Soricimed Biopharma Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 12
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 12 pharmaceutical patents matching "Soricimed Biopharma Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

12 results for “Soricimed Biopharma Inc.” · 30,257 patents in full index Clear search

  1. US 12239729

    TRPV3 agonists for the treatment of skin conditions

    Soricimed Biopharma Inc. · Granted Mar 4, 2025 · Expires Feb 27, 2045

    granted
  2. US 11090396

    Compounds and methods for the detection of TRPV-6 cancers and drug delivery

    Soricimed Biopharma Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  3. US 10864152

    TRPV3 agonists for the treatment of skin conditions

    Soricimed Biopharma Inc. · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted
  4. US 10064964

    Compounds and methods for the detection of TRPV-6 cancers and drug delivery

    Soricimed Biopharma Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  5. US 10058587

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Soricimed Biopharma Inc. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted
  6. US 9303077

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Soricimed Biopharma Inc. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted
  7. US 8962817

    Vectors encoding a paralytic peptide

    Soricimed Biopharma Inc. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  8. US 8673858

    Method for treating wrinkles using a paralytic peptide from the shrew Blarina brevicauda

    Soricimed Biopharma Inc. · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  9. US 8618058

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Soricimed Biopharma Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted
  10. US 8338136

    Method of producing a paralytic peptide

    Soricimed Biopharma Inc. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  11. US 8211857

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Soricimed Biopharma Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  12. US 8003754

    Paralytic peptide for use as a insecticide

    Soricimed Biopharma Inc. · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted